Nexpowder— 510(k) K202929

Substantially Equivalent

Nextbiomedical Co., Ltd.

FDA 510(k) clearance K202929 for Nexpowder, Substantially Equivalent on 2022-09-16. Applicant: Nextbiomedical Co., Ltd..

Clearance details

Applicant: Nextbiomedical Co., Ltd.
Product code: Code QAU
Advisory panel: General, Plastic Surgery
Date received: 2020-09-29
Decision date: 2022-09-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Incheon, KR

Download summary PDF View on FDA.gov ↗

Adverse events under product code QAU

product code QAU

Death: 6
Injury: 135
Malfunction: 621
Total: 762

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.